An official website of the United States government Here's how you know

U.S. Department of Health and Human Services | National Institutes of Health

Official websites use .gov
A .gov website belongs to an official government
organization in the United States.

Secure .gov websites use HTTPS
A lock (🔒) or https:// means you've safely connected to the .gov website.
Share sensitive information only on official, secure websites.

Dolutegravir for the Treatment of HIV in Patients with Tuberculosis in Kwazulu-Natal South Africa

Related Resources

The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).

Funding Fogarty Program

Emerging Global Leader

Project Information in NIH RePORTER

Dolutegravir for the Treatment of HIV in Patients with Tuberculosis in Kwazulu-Natal South Africa

Principal Institution

Center for the AIDS Program of Research in South Africa (CAPRISA)

Principal Investigator(s) (PI)

Naidoo, Anushka

Project Contact Information

Email: anushka.naidoo@caprisa.org

Year(s) Awarded

2019-2024

Country

South Africa

Collaborators

Johns Hopkins University

Related World Regions / Countries

Sub-Saharan Africa

Dolutegravir for the Treatment of HIV in Patients with Tuberculosis in Kwazulu-Natal South Africa